{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T21:02:45Z","timestamp":1778706165020,"version":"3.51.4"},"reference-count":11,"publisher":"Elsevier BV","issue":"16","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.bmcl.2015.05.074","type":"journal-article","created":{"date-parts":[[2015,5,30]],"date-time":"2015-05-30T11:50:18Z","timestamp":1432986618000},"page":"3270-3274","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Design, synthesis and evaluation of MCH receptor 1 antagonists\u2014Part II: Optimization of pyridazines toward reduced phospholipidosis and hERG inhibition"],"prefix":"10.1016","volume":"25","author":[{"given":"Gerald J.","family":"Roth","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armin","family":"Heckel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rg T.","family":"Kley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thorsten","family":"Lehmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan G.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thorsten","family":"Oost","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaus","family":"Rudolf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirsten","family":"Arndt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralph","family":"Budzinski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Lenter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralf R.H.","family":"Lotz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcus","family":"Schindler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leo","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirk","family":"Stenkamp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2015.05.074_b0005","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nrd2005","volume":"51","author":"Grundy","year":"2006","journal-title":"Nat. Rev. Drug Disc."},{"key":"10.1016\/j.bmcl.2015.05.074_b0010","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s12031-010-9411-4","volume":"43","author":"Chung","year":"2011","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.bmcl.2015.05.074_b0015","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1517\/13543776.2011.575063","volume":"21","author":"Johannson","year":"2011","journal-title":"Expert Opin. Ther. Patents"},{"key":"10.1016\/j.bmcl.2015.05.074_b0020","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1517\/14740338.5.4.567","volume":"5","author":"Reasor","year":"2006","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.bmcl.2015.05.074_b0025","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.drudis.2007.08.010","volume":"12","author":"M\u00e9ndez-Andino","year":"2007","journal-title":"Drug Discovery Today"},{"key":"10.1016\/j.bmcl.2015.05.074_b0030","doi-asserted-by":"crossref","first-page":"6039","DOI":"10.1016\/j.bmcl.2012.08.025","volume":"22","author":"H\u00f6gberg","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bmcl.2015.05.074_b0035","doi-asserted-by":"crossref","unstructured":"M\u00fcller, S. G.; Heckel, A.; Kley, J. T.; Lehmann, T.; Lustenberger, P.; Oost, T.; Roth, G. J.; Rudolf, K.; Arndt, K.; Lenter, M.; Schindler, M.; Lotz, R. R. H.; Maier, G.-M.; Markert, M.; Thomas, L.; Stenkamp, D. Bioorg. Med. Chem. Lett. 2015, 25, 3264.","DOI":"10.1016\/j.bmcl.2015.05.077"},{"key":"10.1016\/j.bmcl.2015.05.074_b0040","first-page":"347","volume":"55","author":"Ploemen","year":"2004","journal-title":"Exp. Toxic Pathol."},{"key":"10.1016\/j.bmcl.2015.05.074_b0045","unstructured":"Chemical procedures and analytical data for all final products and intermediates mentioned above can be found. In: Roth, G. J.; M\u00fcller, S. G.; Lehmann-Lintz, T.; Stenkamp, D.; Lustenberger, P.; Kley, J.; Rudolf, K.; Heckel, A.; Schindler, M.; Thomas, L,: Lotz, R. H. WO07048802, 2007."},{"key":"10.1016\/j.bmcl.2015.05.074_h0050","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/S0006-2952(97)82443-4","volume":"53","author":"Xia","year":"1997","journal-title":"Biochem. Pharm."},{"key":"10.1016\/j.bmcl.2015.05.074_h0055","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1023\/A:1024778329320","volume":"19","author":"Casartelli","year":"2003","journal-title":"Cell Biol. Toxicol."}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X1500548X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X1500548X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:03:32Z","timestamp":1760771012000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X1500548X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":11,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S0960894X1500548X"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2015.05.074","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis and evaluation of MCH receptor 1 antagonists\u2014Part II: Optimization of pyridazines toward reduced phospholipidosis and hERG inhibition","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2015.05.074","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}